Sensyne Health
Sensyne Health uses AI to analyze patient data and improve medicine development and patient care.
Sensyne Health uses AI to analyze patient data and improve medicine development and patient care.
Sensyne Health is a United Kingdom-based healthcare technology firm that leverages artificial intelligence (AI) to drive innovation in the medical field. Founded in 2018, the company's primary focus lies in utilizing AI to analyze patient data and enhance both medicine development and patient care. Sensyne Health collaborates with NHS Trusts, using de-identified patient data from extensive databases to derive real-world evidence, thus expediting the discovery and advancement of new medications. Their last investment of £27.50M in post-IPO equity occurred on 09 December 2020. With its cutting-edge approach, Sensyne Health is at the forefront of revolutionizing healthcare by combining technological advancements with the medical domain to improve patient outcomes and pharmaceutical development.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | £27.50M | - | 09 Dec 2020 | |
| Venture Round | £5.00M | 1 | Chelsea and Westminster Hospital | 01 Aug 2018 |
No recent news or press coverage available for Sensyne Health.
We care about your data, and we'd love to use cookies make your experience better.
